1. National Institute for Health Research. Clinical Trials Toolkit: Trial Management & Monitoring.
http://www.ct-toolkit.ac.uk/routemap/trial-management-and-monitoring/
. Accessed 1 June 2020.
2. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guideline for good clinical practice E6(R1) - ICH harmonised tripartite guideline. 1996.
https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e6-r1-guideline-good-clinical-practice_en.pdf
. Accessed 1 June 2020.
3. Medical Research Council. MRC guidelines for management of global health trials involving clinical or public health interventions, 2017, version 3.0 (09 Oct 2019).
https://mrc.ukri.org/documents/pdf/guidelines-for-management-of-global-health-trials/
. Accessed 1 June 2020.
4. Buck D, Gamble C, Dudley L, Preston J, Hanley B, Williamson PR, et al. From plans to actions in patient and public involvement: qualitative study of documented plans and the accounts of researchers and patients sampled from a cohort of clinical trials. BMJ Open. 2014;4(12):e006400.
5. Dudley L, Gamble C, Preston J, Buck D, Hanley B, Williamson P, et al. What difference does patient and public involvement make and what are its pathways to impact? Qualitative study of patients and researchers from a cohort of randomised clinical trials. PLoS One. 2015;10(6):e0128817.